REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 77 filers reported holding REPARE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,002 | +214.1% | 6,126 | +175.1% | 0.00% | +100.0% |
| Q2 2023 | $23,562 | +21127.0% | 2,227 | -80.3% | 0.00% | -75.0% |
| Q1 2023 | $111 | +326.9% | 11,316 | +533.2% | 0.00% | +300.0% |
| Q4 2022 | $26 | -100.0% | 1,787 | -80.9% | 0.00% | -50.0% |
| Q3 2022 | $113,000 | +61.4% | 9,335 | +90.2% | 0.00% | +100.0% |
| Q1 2022 | $70,000 | – | 4,909 | +44527.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 11 | -94.4% | 0.00% | – |
| Q3 2021 | $5,000 | -95.5% | 196 | -94.5% | 0.00% | -100.0% |
| Q2 2021 | $110,000 | +12.2% | 3,536 | +9.6% | 0.00% | +50.0% |
| Q1 2021 | $98,000 | +58.1% | 3,225 | +78.6% | 0.00% | 0.0% |
| Q4 2020 | $62,000 | – | 1,806 | +90200.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 2 | -99.8% | 0.00% | -100.0% |
| Q2 2020 | $27,000 | – | 873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |